SfN 2024: Where neuroscience meets community, collaboration, and innovation

At SfN 2024, neuroscientists converge to share groundbreaking research, fostering interdisciplinary connections and advancing the understanding of the brain.

How one lab’s decadeslong search for the ‘holy grail’ of sickle cell led to the first CRISPR therapy

In a 2008 issue of Science, just a page apart, were the two crucial discoveries that would form the cure for sickle cell disease. Stuart

December 9, 2023

PDS-01ADC by PDS Biotechnology for Colorectal Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

January 4, 2024

Cambridge University spinout raises £48m to advance T-cell therapies – Pharmaceutical Technology

Share this article T-Therapeutics has developed a proprietary transgenic mouse platform, OpTiMus. Image Credit: Lemonsoup14 / Shutterstock. A University of Cambridge spinout T-Therapeutics has raised

November 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.